ProfileGDS4718 / 1568796_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 54% 57% 57% 50% 59% 60% 58% 58% 52% 56% 54% 60% 52% 59% 58% 57% 54% 59% 49% 58% 58% 50% 54% 57% 57% 59% 53% 54% 58% 60% 55% 58% 58% 53% 53% 56% 60% 59% 56% 59% 57% 55% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8815856
GSM549102patient 115, normal, homogenized [OPG study]5.7865354
GSM549104patient 119, normal, homogenized [OPG study]5.917457
GSM549108patient 138, normal, homogenized [OPG study]5.9684657
GSM549119patient 077, normal, homogenized [OPG study]5.5494550
GSM549133patient 032, cancer, homogenized [OPG study]6.035759
GSM549139patient 042, cancer, homogenized [OPG study]6.1498660
GSM549099patient 107, normal, homogenized [OPG study]5.9651358
GSM549109patient 139, normal, homogenized [OPG study]5.9981758
GSM549110patient 046, normal, homogenized [OPG study]5.5987352
GSM549114patient 063, normal, homogenized [OPG study]5.8331256
GSM549122patient 082, normal, homogenized [OPG study]5.7445554
GSM549134patient 033, cancer, homogenized [OPG study]6.1023860
GSM549136patient 036, cancer, homogenized [OPG study]5.5922852
GSM549140patient 044, cancer, homogenized [OPG study]6.0098559
GSM549111patient 047, normal, homogenized [OPG study]5.9993358
GSM549113patient 057, normal, homogenized [OPG study]5.8615257
GSM549132patient 031, cancer, homogenized [OPG study]5.7374654
GSM549137patient 038, cancer, homogenized [OPG study]6.051359
GSM549142patient 047, cancer, homogenized [OPG study]5.5872649
GSM549100patient 110, normal, homogenized [OPG study]6.0159458
GSM549107patient 135, normal, homogenized [OPG study]5.9912458
GSM549115patient 068, normal, homogenized [OPG study]5.487850
GSM549116patient 072, normal, homogenized [OPG study]5.7254154
GSM549120patient 078, normal, homogenized [OPG study]5.9266157
GSM549131patient 030, cancer, homogenized [OPG study]5.917557
GSM549118patient 074, normal, homogenized [OPG study]6.069259
GSM549129patient 027, cancer, homogenized [OPG study]5.7168553
GSM549123patient 088, normal, homogenized [OPG study]5.7242954
GSM549124patient 006, cancer, homogenized [OPG study]6.0137958
GSM549126patient 015, cancer, homogenized [OPG study]6.1349360
GSM549128patient 025, cancer, homogenized [OPG study]5.8186955
GSM549103patient 117, normal, homogenized [OPG study]6.0196958
GSM549117patient 073, normal, homogenized [OPG study]5.9416258
GSM549138patient 041, cancer, homogenized [OPG study]5.6958253
GSM549141patient 045, cancer, homogenized [OPG study]5.6880553
GSM549130patient 028, cancer, homogenized [OPG study]5.8743956
GSM549101patient 111, normal, homogenized [OPG study]6.1299860
GSM549105patient 128, normal, homogenized [OPG study]6.0700559
GSM549106patient 134, normal, homogenized [OPG study]5.8336756
GSM549112patient 048, normal, homogenized [OPG study]6.0754259
GSM549125patient 011, cancer, homogenized [OPG study]5.9577157
GSM549127patient 024, cancer, homogenized [OPG study]5.8255255
GSM549135patient 035, cancer, homogenized [OPG study]5.9845158